$ALDX News Article - Aldeyra Therapeutics Achieves
Post# of 46
(Total Views: 277)
Posted On: 04/27/2021 10:25:48 AM
$ALDX News Article - Aldeyra Therapeutics Achieves Statistical Significance for Primary Endpoint and All Secondary Endpoints in Phase 3 INVIGORATE Clinical Trial of Reproxalap in Allergic Conjunctivitis https://marketwirenews.com/news-releases/alde...68103.html
(0)
(0)Aldeyra Therapeutics Inc. (ALDX) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼